| 摘要 |
The present invention is directed to the use of (R)-2-propyloctanoic acid, a non-toxic salt thereof or a hydrate thereof and a tissue plasminogen activator for the manufacture of an agent for improving neurological symptom in cerebral ischemic disease.
|
